quetiapine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on serious adverse event incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Moreover, there was no significant difference between quetiapine and placebo in the likelihood of having at least one serious adverse event (RR 0.85, 95% CI 0.49 to 1.48).”
Quoted verbatim from Quetiapine for acute bipolar depression: a systematic review and meta-analysis.. - Study
- meta-analysis
- Dose
- 150-600 mg/day
- Population
- Adults and children/adolescents with acute bipolar I or II depression; pooled RCTs of quetiapine versus placebo
Effect 0.85 risk ratio, 95% CI 0.49 to 1.48
Quetiapine for acute bipolar depression: a systematic review and meta-analysis.2014PMID:25028535Permalink
Keep reading
- Everything the graph holds on quetiapine
- Every compound studied against Serious adverse event incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45ADD4JJ4EQ5WT2V5M33ER0